publication_id,tool,quote,best_match_source,best_match,similarity
1528,PRECIS-2,Effectiveness was initially defined as the change in EQ-5D scores and a cost-effectiveness analysis was performed using this outcome measure.,fulltext,Effectiveness was initially defined as the change in EQ-5D scores and a cost-effectiveness analysis was performed using this outcome measure.,100.0
1528,PRECIS-2,"Participants were included who scored >2 on the General Health Questionnaire 12, a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, thus confirming they had low mood.",fulltext,"participants were included who scored >2 on the General Health Questionnaire 12, 7 a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, 8 thus confirming they had low mood.",100.0
1528,PRECIS-2,Those allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.,fulltext,Those allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.,100.0
1528,PRECIS-2,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",fulltext,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",100.0
1528,PRECIS-2,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",fulltext,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",100.0
1529,PRECIS-2,This study was conducted in 2015e2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,fulltext,This clinical trial was conducted in 2015e2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,98.1651376146789
1529,PRECIS-2,"To assess the reliability of the instruments used in this study, split-half reliability was used. Pearson's correlation coefficient was estimated to be 0.79 and 0.89 for the half of the DASS-21 and the Piper Standard Scale, respectively.",fulltext,"To assess the reliability of the instruments used in this study, split-half reliability was used. Pearson's correlation coefficient was estimated to be 0.79 and 0.89 for the half of the DASS-21 and the Piper Standard Scale, respectively.",100.0
1529,PRECIS-2,"To investigate depression, anxiety, and stress, DASS-21, developed by Lovibond and Lovibond in 1995, was used and its validity and reliability were confirmed [17]. To measure fatigue, the Piper Standard Scale was used.",fulltext,"To investigate depression, anxiety, and stress, DASS-21, developed by Lovibond and Lovibond in 1995, was used and its validity and reliability were confirmed [17]. To measure fatigue, the Piper Standard Scale was used.",100.0
1529,PRECIS-2,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",fulltext,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",100.0
1529,PRECIS-2,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted. For blinding, the patients of the control group referred to the Society on certain days of week and those of the experimental on other days.",fulltext,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted. For blinding, the patients of the control group referred to the Society on certain days of week and those of the experimental on other days.",100.0
1529,PRECIS-2,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",fulltext,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",100.0
1567,PRECIS-2,"The 70-min battery included the following widely used tests: the Controlled Oral Word Association Test (COWAT) - verbal fluency and word finding; The California Verbal Learning Test, 2nd ed, (CVLT-II) - verbal learning and remembering; The Brief Visuospatial Memory Test e Revised (BVMT-R) - nonverbal learning and memory; The Paced Auditory Serial Addition Test (PASAT) - auditory information processing speed and flexibility, as well as calculation abilities; and The Symbol Digit Modalities Test (SDMT) - complex scanning and visual tracking.",fulltext,"The 70-min battery included the following widely used tests: the Controlled Oral Word Association Test (COWAT) 26 - verbal fluency and word finding; The California Verbal Learning Test, 2nd ed, (CVLT-II) 27 - verbal learning and remembering; The Brief Visuospatial Memory Test e Revised (BVMT-R) 28 nonverbal learning and memory; The Paced Auditory Serial Addition Test (PASAT) 29 - auditory information processing speed and flexibility, as well as calculation abilities; and The Symbol Digit Modalities Test (SDMT) 30 - complex scanning and visual tracking.",99.81651376146789
1567,PRECIS-2,"For the current study, we employed intention-to-treat strategies to handle missing data using a “last observation carried forward” (LOCF) strategy in which missing data points are imputed based on the participant's existing data.",fulltext,"For the current study, we employed intention-to-treat strategies to handle missing data using a “last observation carried forward” (LOCF) strategy in which missing data points are imputed based on the participant's existing data.",100.0
1567,PRECIS-2,Persons with MS (N 1⁄4 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.,fulltext,Persons with MS (N ¼ 183) with cognitive concerns were randomly assigned to either the 8week MAPSS-MS intervention or usual care plus freely available computer games.,97.63313609467455
1567,PRECIS-2,"The primary purpose of this study was to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",fulltext,"The primary purpose of this study was to determine the effectiveness of a novel computerassisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",99.57983193277312
1567,PRECIS-2,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy.",fulltext,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy.",100.0
1567,PRECIS-2,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.",fulltext,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.",100.0
1567,PRECIS-2,"The Perceived Deficits Questionnaire was administered by phone, and those scoring at least 10 (indicating some problems in at least 5 areas) were eligible to participate.",fulltext,"The Perceived Deficits Questionnaire 19 was administered by phone, and those scoring at least 10 (indicating some problems in at least 5 areas) were eligible to participate.",100.0
1567,PRECIS-2,"Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",fulltext,"Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",100.0
1568,PRECIS-2,"Global brain atrophy rate was quantified by the two most common methods found in the MS literature. First, as percentage brain volume change (PBVC) determined by the automated longitudinal brain change analysis tool, SIENA, part of FSL,15 using improved brain masks16 and second as percentage change of brain parenchymal fraction (BPF).",fulltext,"Global brain atrophy rate was quantified by the two most common methods found in the MS literature. First, as percentage brain volume change (PBVC) determined by the automated longitudinal brain change analysis tool, SIENA, part of FSL, 15 using improved brain masks 16 and second as percentage change of brain parenchymal fraction (BPF).",100.0
1568,PRECIS-2,Patients received the exercise intervention in addition to usual care.,fulltext,Patients received the exercise intervention in addition to usual care.,100.0
1568,PRECIS-2,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",fulltext,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",100.0
1568,PRECIS-2,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",prompt,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",100.0
1568,PRECIS-2,"In brief, the exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRmax.",fulltext,"In brief, the exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRma",98.29059829059828
1568,PRECIS-2,A multivariate repeated measurements mixed effects regression model was used to analyse longitudinal data with time and group as fixed effects.,fulltext,A multivariate repeated measurements mixed effects regression model was used to analyse longitudinal data with time and group as fixed effects.,100.0
1568,PRECIS-2,"The exercise intervention was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan)13: (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",fulltext,"d was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) 13 : (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",92.2360248447205
1568,PRECIS-2,The present study is a national multicentre single-blinded parallel group randomized controlled trial (RCT) comparing two groups receiving either supervised exercise therapy (intervention group) or health education (active control group).,fulltext,The present study is a national multicentre singleblinded parallel group randomized controlled trial (RCT) comparing two groups receiving either supervised exercise therapy (intervention group) or health education (active control group).,99.57983193277312
1568,PRECIS-2,"Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1568,PRECIS-2,Patients were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,fulltext,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,100.0
1569,PRECIS-2,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,fulltext,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,100.0
1569,PRECIS-2,"Inclusion criteria—Males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5.",fulltext," inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5",99.58847736625515
1569,PRECIS-2,"During TOCT, they received feedback (visual and auditory) from the physiotherapist.",fulltext,"During TOCT, they received feedback (visual and auditory) from the physiotherapist.",100.0
1569,PRECIS-2,The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance.,fulltext,The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance.,100.0
1569,PRECIS-2,The methodology of how to deliver an intervention is not rigidly prescriptive in the protocol.,prompt,The methodology of how to deliver an intervention is not rigidly prescriptive in the protocol.,100.0
1569,PRECIS-2,"This work is part of a larger project concerned with ensuring that trials are designed so that their results are relevant to, and used by, patients, clinicians, and policy decision makers.",prompt,"This work is part of a larger project concerned with ensuring that trials are designed so that their results are relevant to, and used by, patients, clinicians, and policy decision makers.",100.0
1569,PRECIS-2,"The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program.",fulltext," The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program",99.6078431372549
1570,PRECIS-2,"At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated (cases of pseudoexacerbation were not considered as relapse).",fulltext,"At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated (cases of pseudoexacerbation were not considered as relapse).",100.0
1570,PRECIS-2,"Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of β-interferon under the supervision of a neurologist in a period of no more than 30 days prior to the study.",fulltext,"iteria: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of βinterferon under the supervision of a neurologist in a period of no more than 30 days prior to t",97.26775956284153
1570,PRECIS-2,"The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005-2006",fulltext,"Methods The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2",95.0920245398773
1570,PRECIS-2,The total sample volume was 90 patients divided into three equal groups.,fulltext,The total sample volume was 90 patients divided into three equal groups.,100.0
1570,PRECIS-2,"According to the inclusion criteria the patients were treated as follows: 30 patients received Av (30 mcg IM on a weekly basis), 30 patients received Re (44 mcg SC three times a week) and 30 patients received Be (250 mcg SC on an alternate day basis).",fulltext,"According to the inclusion criteria the patients were treated as follows: 30 patients received Av (30 mcg IM on a weekly basis), 30 patients received Re (44 mcg SC three times a week) and 30 patients received Be (250 mcg SC on an alternate day basis).",100.0
1570,PRECIS-2,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",fulltext,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",100.0
1769,PRECIS-2,There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,fulltext,There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,100.0
1769,PRECIS-2,"The treated group were given corticotrophin (’Acthar’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",fulltext,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",100.0
1769,PRECIS-2,"Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial, and these cases were initially assessed and scored during an inactive phase of the disease.",fulltext,"Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial, and these cases were initially assessed and scored during an inactive phase of the disease.",100.0
1769,PRECIS-2,To obtain an adequate number of cases for statistical purposes similar studies were carried out at the same time in three cities and this had the added advantage that they could,fulltext,To obtain an adequate number of cases for statistical purposes similar studies were carried out at the same time in three cities and this had the added advantage that they could,100.0
1769,PRECIS-2,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same.",fulltext,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same.",100.0
1769,PRECIS-2,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,fulltext,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,100.0
1769,PRECIS-2,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,fulltext,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,100.0
1769,PRECIS-2,one another.,fulltext,one another.,100.0
1770,PRECIS-2,"Three patients were withdrawn because of subsequent treatment with ACTH, corticosteroids or immunosuppressive drugs during the follow-up period.",fulltext,"Three patients were withdrawn because of subsequent treatment with ACTH, corticosteroids or immunosuppressive drugs during the follow-up period.",100.0
1770,PRECIS-2,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",fulltext,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",100.0
1770,PRECIS-2,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1770,PRECIS-2,"Patients with contraindications to bed rest or ACTH-treatment, such as hypersensitivity to ACTH, acute infections, cardial insufficiency, psychosis, pregnancy, Cushing syndrome or peptic ulcer, were excluded.",fulltext,"Patients with contraindications to bed rest or ACTH-treatment, such as hypersensitivity to ACTH, acute infections, cardial insufficiency, psychosis, pregnancy, Cushing syndrome or peptic ulcer, were excluded.",100.0
1770,PRECIS-2,"Only patients with a clinical or laboraton- sup-ported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",fulltext," ported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",70.06369426751593
1770,PRECIS-2,"Data collected at entry included: age, sex, duration of MS, course of the disease, i.e. relapsing remitting (RR), progressive after an RR-period (PR), and primarily progressive (PP); duration of the present relapse, intensity of the relapse on a 4-point scale (mild - moderate - severe - very severe); symptoms of the relapse; neurological dysfunction, scored according to the Kurtzke expanded disability status scale (EDSS) (7) at entry and estimated at the point before the relapse; Kurtzke functional systems (FS) (7), and ambulation index (AI) (8); activities of daily living, scored in the incapacity status scale (ISS) (7).",fulltext,"Data collected at entry included: age, sex, duration of MS, course of the disease, i.e. relapsing remitting (RR), progressive after an RR-period (PR), and primarily progressive (PP); duration of the present relapse, intensity of the relapse on a 4-point scale (mild - moderate - severe - very severe); symptoms of the relapse; neurological dysfunction, scored according to the Kurtzke expanded disability status scale (EDSS) (7) at entry and estimated at the point before the relapse; Kurtzke functional systems (FS) (7), and ambulation index (AI) (8); activities of daily living, scored in the incapacity status scale (ISS) (7).",100.0
1770,PRECIS-2,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depotpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5).",fulltext,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depotpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5)",99.65156794425087
1770,PRECIS-2,Assessment of patients was performed by their own neurologist.,fulltext,Assessment of patients was performed by their own neurologist.,100.0
1771,PRECIS-2,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO2-max test). Each test session was separated by at least 48 hours from the last exercise bout.",fulltext,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO 2 -max test). Each test session was separated by at least 48 hours from the last exercise bout.",100.0
1771,PRECIS-2,"For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see Langeskov-Christensen et al.23",fulltext,"For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see LangeskovChristensen et al. ",98.0
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see Langeskov-Christensen et al.24",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see LangeskovChristensen et al. ",98.87640449438202
1771,PRECIS-2,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",fulltext,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",100.0
1771,PRECIS-2,"To investigate the effects of PAE on the cognitive domains of information processing, learning and memory, and verbal fluency in pwMS.",fulltext,"To investigate the effects of PAE on the cognitive domains of information processing, learning and memory, and verbal fluency in pwMS.",100.0
1771,PRECIS-2,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions.",fulltext,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions.",100.0
1771,PRECIS-2,All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest.,fulltext,All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest.,100.0
1771,PRECIS-2,"Following inclusion and baseline testing, participants were randomized (1:1) to a PAE or waitlist group using block randomization, stratified by sex.",fulltext,"Following inclusion and baseline testing, participants were randomized (1:1) to a PAE or waitlist group using block randomization, stratified by sex.",100.0
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",100.0
1771,PRECIS-2,"Assessments included the Brief Repeatable Battery of Neuropsychological tests (BRB-N), self-reported mood, and cardiorespiratory fitness.",fulltext,"Assessments included the Brief Repeatable Battery of Neuropsychological tests (BRB-N), self-reported mood, and cardiorespiratory fitness.",100.0
1771,PRECIS-2,"In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate (HRmax).",fulltext,"In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity M Langeskov-Christensen, LG Hvid et al. journals.sagepub.com/home/msj 3 increased from 65% to 95% of individual maximum heart rate (HR max ",99.4186046511628
1772,PRECIS-2,"For patients from the USA, the treating physician determined whether the patient was a suitable candidate for therapy change. In the case of Canadian patients, only those with relapsing–remitting MS and who had an inadequate response to, or were unable to tolerate, one or more therapies for MS were eligible.",fulltext,". For patients from the USA, the treating physician determined whether the patient was a suitable candidate for therapy change. In the case of Canadian patients, only those with relapsing–remitting MS and who had an inadequate response to, or were unable to tolerate, one or more therapies for MS were eligibl",99.35275080906149
1772,PRECIS-2,The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months.,fulltext,t The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 month,98.66666666666667
1772,PRECIS-2,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",prompt,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",100.0
1772,PRECIS-2,"Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria, and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were eligible to participate in the study.",fulltext,"a Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) Calkwood et al. BMC Neurology 2014, 14:220 Page 2 of 11 http://www.biomedcentral.com/1471-2377/14/220 score of 0–5.5 were eligible to participate in the stud",99.06103286384976
1772,PRECIS-2,Missing data were imputed using the last observation carried forward.,fulltext,. Missing data were imputed using the last observation carried forwar,97.10144927536231
1773,PRECIS-2,Extra test—Randomised controlled trial of Bell’s palsy treatment required senior otorhinolaryngologist in hospitals to confirm a patient’s eligibility to participate. Bell’s palsy is usually diagnosed by a general practitioner in primary care.,prompt,Extra test—Randomised controlled trial of Bell’s palsy treatment required senior otorhinolaryngologist in hospitals to confirm a patient’s eligibility to participate. Bell’s palsy is usually diagnosed by a general practitioner in primary care.,100.0
1773,PRECIS-2,"Test not routinely used in primary care and requires training. It is, however, an easy clinical test widely used in secondary care for grading recovery from facial nerve paralysis caused by damage to lower motor neurons.",prompt,"Test not routinely used in primary care and requires training. It is, however, an easy clinical test widely used in secondary care for grading recovery from facial nerve paralysis caused by damage to lower motor neurons.",100.0
1773,PRECIS-2,Primary outcome—Recovery of facial function as rated on the House-Brackmann scale.,prompt,Primary outcome—Recovery of facial function as rated on the House-Brackmann scale.,100.0
1773,PRECIS-2,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",prompt,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",100.0
1773,PRECIS-2,"Monitoring intensity involved more extensive data collection than usual: Pre-operation—three-lead electrocardiogram (ECG) Holter monitor (Flashcard with 2×48 hour recording) set up on each patient and maintained for 72 hours. Troponin values at 1, 3, and 7 days after surgery (more usual for only 1 and 3 days after surgery) ECG after randomisation and at 7 and 30 days after surgery.",prompt,"Monitoring intensity involved more extensive data collection than usual: Pre-operation—three-lead electrocardiogram (ECG) Holter monitor (Flashcard with 2×48 hour recording) set up on each patient and maintained for 72 hours. Troponin values at 1, 3, and 7 days after surgery (more usual for only 1 and 3 days after surgery) ECG after randomisation and at 7 and 30 days after surgery.",100.0
1773,PRECIS-2,"Central adjudication—Photographs taken of patients were assessed and graded independently by a panel of three experts (not general practitioners, who usually assess).",prompt,"Central adjudication—Photographs taken of patients were assessed and graded independently by a panel of three experts (not general practitioners, who usually assess).",100.0
1773,PRECIS-2,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",prompt,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",100.0
1773,PRECIS-2,"Single centre and specialised centre (Madigan Army Medical Center, USA), unlikely to be the usual setting for most individuals receiving physiotherapy for shoulder impingement.",prompt,"Single centre and specialised centre (Madigan Army Medical Center, USA), unlikely to be the usual setting for most individuals receiving physiotherapy for shoulder impingement.",100.0
1773,PRECIS-2,"Unscheduled follow-up visits triggered by primary outcome: a cardiovascular event (such as angina, myocardial infarction, stroke)",prompt,"Unscheduled follow-up visits triggered by primary outcome: a cardiovascular event (such as angina, myocardial infarction, stroke)",100.0
1773,PRECIS-2,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,prompt,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,100.0
648,PRECIS-2,"Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies.",fulltext,"Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies.",100.0
648,PRECIS-2,"The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit.",fulltext,"The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit.",100.0
648,PRECIS-2,Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit.,fulltext,Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit.,100.0
648,PRECIS-2,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.",fulltext,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.",100.0
648,PRECIS-2,"Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent.",fulltext,"Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent.",100.0
648,PRECIS-2,"In particular, there were no restrictions on the type of suture material that could be used, and standard measures to achieve haemostasis were employed regardless of the allocated intervention.",fulltext,"In particular, there were no restrictions on the type of suture material that could be used, and standard measures to achieve haemostasis were employed regardless of the allocated intervention.",100.0
648,PRECIS-2,"Each regional coordinator (one per country, except India, which was split into two regions) started and documented a training programme that ensured that surgeons operating within the trial were familiar with the techniques being compared before participating.",fulltext,"Each regional coordinator (one per country, except India, which was split into two regions) started and documented a training programme that ensured that surgeons operating within the trial were familiar with the techniques being compared before participating.",100.0
648,PRECIS-2,"Women were not eligible if there was a clear indication for a particular surgical technique or material to be used that prevented any of the allocated interventions being used, if they had more than one previous caesarean section, or if they had already been recruited into the trial.",fulltext,"Women were not eligible if there was a clear indication for a particular surgical technique or material to be used that prevented any of the allocated interventions being used, if they had more than one previous caesarean section, or if they had already been recruited into the trial.",100.0
648,PRECIS-2,"CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",fulltext,"CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",100.0
648,PRECIS-2,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,fulltext,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,100.0
648,PRECIS-2,Women were analysed in the groups into which they were allocated.,fulltext,Women were analysed in the groups into which they were allocated.,100.0
650,PRECIS-2,Patients with a clinically established diagnosis of type 2 diabetes mellitus were sent a letter by their GPs to introduce the SMS project.,fulltext,Patients with a clinically established diagnosis of type 2 diabetes mellitus were sent a letter by their GPs to introduce the SMS project.,100.0
650,PRECIS-2,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,fulltext,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,100.0
650,PRECIS-2,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",fulltext,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",100.0
650,PRECIS-2,Patients received the posted screening questionnaire 4–6 weeks before a planned diabetes consultation.,fulltext,patients received the posted screening questionnaire 4–6 weeks before a planned diabetes consultation.,100.0
650,PRECIS-2,PNs in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.,fulltext,s in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.,97.95918367346938
650,PRECIS-2,The study was conducted between November 2011 and February 2013 and was registered in a Dutch public trial registry [NTR2764].,fulltext,The study was conducted between November 2011 and February 2013 and was registered in a Dutch public trial registry [NTR2764].,100.0
650,PRECIS-2,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,fulltext,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,100.0
651,PRECIS-2,"Identical organisation to usual care, usual clinic. Same number of staff. Usual experience—fully qualified ophthalmologists who have completed general and specialist training (in ophthalmology and glaucoma, respectively) and able to perform lens extraction procedures. No additional training. No additional resources.",prompt,"Identical organisation to usual care, usual clinic • Same number of staff • Usual experience—fully qualified ophthalmologists who have completed general and specialist training (in ophthalmology and glaucoma, respectively) and able to perform lens extraction procedures • No additional training • No additional resources ",100.0
651,PRECIS-2,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",prompt,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",100.0
651,PRECIS-2,The sessions were all individual based on interaction with child and allowed for range of responses to the intervention.,prompt,The sessions were all individual based on interaction with child and allowed for range of responses to the intervention.,100.0
651,PRECIS-2,"Monitoring intensity involved more extensive data collection than usual: Pre-operation—three-lead electrocardiogram (ECG) Holter monitor (Flashcard with 2×48 hour recording) set up on each patient and maintained for 72 hours. Troponin values at 1, 3, and 7 days after surgery (more usual for only 1 and 3 days after surgery) ECG after randomisation and at 7 and 30 days after surgery.",prompt,"Monitoring intensity involved more extensive data collection than usual: Pre-operation—three-lead electrocardiogram (ECG) Holter monitor (Flashcard with 2×48 hour recording) set up on each patient and maintained for 72 hours. Troponin values at 1, 3, and 7 days after surgery (more usual for only 1 and 3 days after surgery) ECG after randomisation and at 7 and 30 days after surgery.",100.0
651,PRECIS-2,Complications—Specific directions for managing complications or side effects,prompt,Complications—Specific directions for managing complications or side effects,100.0
651,PRECIS-2,Intention-to-treat principle was applied with multiple imputation of data,prompt,Intention-to-treat principle was applied with multiple imputation of data,100.0
651,PRECIS-2,Co-interventions—Specific direction,prompt,Co-interventions—Specific direction,100.0
651,PRECIS-2,"Primary outcome—Recovery of facial function as rated on the House-Brackmann scale. Test not routinely used in primary care and requires training. It is, however, an easy clinical test widely used in secondary care for grading recovery from facial nerve paralysis caused by damage to lower motor neurons.",prompt," Primary outcome—Recovery of facial function as rated on the House-Brackmann scale. • Test not routinely used in primary care and requires training. It is, however, an easy clinical test widely used in secondary care for grading recovery from facial nerve paralysis caused by damage to lower motor neurons",99.66996699669967
651,PRECIS-2,"Initially extra resources were used to recruit patients at 53 primary care practices. Patients were recruited via a postal questionnaire to identify symptoms and trial eligibility, not just to invite to participate.",prompt,"Initially extra resources were used to recruit patients at 53 primary care practices. Patients were recruited via a postal questionnaire to identify symptoms and trial eligibility, not just to invite to participate.",100.0
651,PRECIS-2,"Protocol driven—Much detail given, with protocol violations recorded in self reported case form. Investigators accept this may occur due to clinical needs (such as anaesthesia).",prompt,"Protocol driven—Much detail given, with protocol violations recorded in self reported case form. Investigators accept this may occur due to clinical needs (such as anaesthesia).",100.0
651,PRECIS-2,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",prompt,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",100.0
651,PRECIS-2,"Single centre and specialised centre (Madigan Army Medical Center, USA), unlikely to be the usual setting for most individuals receiving physiotherapy for shoulder impingement.",prompt,"Single centre and specialised centre (Madigan Army Medical Center, USA), unlikely to be the usual setting for most individuals receiving physiotherapy for shoulder impingement.",100.0
651,PRECIS-2,"Central adjudication—Photographs taken of patients were assessed and graded independently by a panel of three experts (not general practitioners, who usually assess).",prompt,"Central adjudication—Photographs taken of patients were assessed and graded independently by a panel of three experts (not general practitioners, who usually assess).",100.0
651,PRECIS-2,"Unscheduled follow-up visits triggered by primary outcome: a cardiovascular event (such as angina, myocardial infarction, stroke)",prompt,"Unscheduled follow-up visits triggered by primary outcome: a cardiovascular event (such as angina, myocardial infarction, stroke)",100.0
651,PRECIS-2,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,prompt,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,100.0
655,PRECIS-2,We think there are four steps to using PRECIS-2,prompt,We think there are four steps to using PRECIS-2,100.0
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.,fulltext,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017,99.32432432432432
655,PRECIS-2,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department. Following completion of this programme, patients were randomly allocated (baseline visit, 0) to either the TelePR programme [intervention group (IG)] or the standard, usual care programme [control group (CG)].",fulltext,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department. Following completion of this programme, patients were randomly allocated (baseline visit, 0) to either the TelePR programme [intervention group (IG)] or the standard, usual care programme [control group (CG)].",100.0
655,PRECIS-2,"In usual care, health professionals encourage patients to take medication or follow therapy as best they can, and such encouragement would not count against a pragmatic design; if it also happens in usual care, allowing it in the trial is a pragmatic design decision.",prompt,"In usual care, health professionals encourage patients to take medication or follow therapy as best they can, and such encouragement would not count against a pragmatic design; if it also happens in usual care, allowing it in the trial is a pragmatic design decision.",100.0
655,PRECIS-2,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.",fulltext,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session ",100.0
655,PRECIS-2,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",fulltext,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",100.0
655,PRECIS-2,Patients were considered non-adherent if they did not attend any 2 follow-up appointments and there was no clear clinical justification for not attending.,fulltext,Patients were considered non-adherent if they did not attend any 2 follow-up appointments and there was no clear clinical justification for not attending.,100.0
655,PRECIS-2,Step 2: Consider your trial design choices for each of the nine PRECIS-2 domains,prompt,Step 2: Consider your trial design choices for each of the nine PRECIS-2 domains,100.0
655,PRECIS-2,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,fulltext,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,100.0
655,PRECIS-2,"A highly pragmatic design would aim to slot the intervention into the usual organisation of care for the condition of interest, making use of no more than the existing healthcare staff and resources in that setting.",prompt,"A highly pragmatic design would aim to slot the intervention into the usual organisation of care for the condition of interest, making use of no more than the existing healthcare staff and resources in that setting.",100.0
655,PRECIS-2,"Most trials are a superiority design so the most pragmatic approach with regard to the analysis would be to make no special allowance in the analysis for non-adherence, practice variability, etc. In other words, the pragmatic approach to the analysis would typically be an intention-to-treat analysis using all available data.",prompt," Most trials are a superiority design so the most pragmatic approach with regard to the analysis would be to make no special allowance in the analysis for non-adherence, practice variability, etc. In other words, the pragmatic approach to the analysis would typically be an intention-to-treat analysis using all available data",99.69325153374233
655,PRECIS-2,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines and having been clinically stable for the previous 4 weeks.",fulltext,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines 9 and having been clinically stable for the previous 4 weeks ",100.0
657,PRECIS-2,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,fulltext,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,100.0
657,PRECIS-2,"Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",fulltext,"Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",100.0
657,PRECIS-2,"The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master’s degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",fulltext,"The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master’s degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",100.0
657,PRECIS-2,"Inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",fulltext,"inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria 27 ; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",100.0
657,PRECIS-2,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,fulltext,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,100.0
657,PRECIS-2,"Assessments were undertaken at baseline and at weeks 7, 18, and 30.",fulltext,"Assessments were undertaken at baseline and at weeks 7, 18, and 30.",100.0
657,PRECIS-2,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,fulltext,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,100.0
657,PRECIS-2,Repeated-measures mixed models were used for statistical analysis.,fulltext,Repeated-measures mixed models were used for statistical analysis.,100.0
657,PRECIS-2,Two assessors masked with regard to the group allocation carried out the assessments.,fulltext,Two assessors masked with regard to the group allocation carried out the assessments.,100.0
657,PRECIS-2,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,fulltext,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,100.0
657,PRECIS-2,"The physical therapists conducted an individual clinical examination of each participant. The examinations were followed by group sessions, in which the physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual’s impairments underlying his or her balance disturbance.",fulltext,"The physical therapists conducted an individual clinical examination of each participant. The examinations were followed by group sessions, in which the physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual’s impairments underlying his or her balance disturbance.",100.0
657,PRECIS-2,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",fulltext,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",100.0
662,PRECIS-2,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",fulltext,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",100.0
662,PRECIS-2,Assessments occurred between January 2013 and October 2013.,fulltext,Assessments occurred between January 2013 and October 2013.,100.0
662,PRECIS-2,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,fulltext,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,100.0
662,PRECIS-2,We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,fulltext,We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,100.0
662,PRECIS-2,The GHQ is designed to measure general levels of distress.,fulltext,The GHQ 17 is designed to measure general levels of distress.,100.0
662,PRECIS-2,"AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner.",fulltext,"AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner.",100.0
662,PRECIS-2,The blinded assessor (SW) notified participants by email when questionnaires were due.,fulltext,The blinded assessor (SW) notified participants by email when questionnaires were due.,100.0
663,PRECIS-2,A follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,fulltext, follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,99.2
663,PRECIS-2,"The BMCT intervention was developed based on previously published programs, and according to principle of the task-oriented approach, thus addressing salient tasks including sitting (5 minutes), standing (5 minutes), stepping (10 minutes), walking (2 × 10 minutes), and eye-movement training (10 minutes; framework illustrated in Supplemental Appendix).",fulltext,"The BMCT intervention was developed based on previously published programs 5,11,18,19 and according to principle of the task-oriented approach, 9 thus addressing salient tasks including sitting (5 minutes), standing (5 minutes), stepping (10 minutes), walking (2 × 10 minutes), and eye-movement training (10 minutes; framework illustrated in Supplemental Appendix).",100.0
663,PRECIS-2,"Two adverse events occurred in the PRT group. One participant experienced exacerbation of fatigue following PRT sessions and dropped out; one experienced intermittent low back pain during PRT, but continued in the study.",fulltext,"Two adverse events occurred in the PRT group. One participant experienced exacerbation of fatigue following PRT sessions and dropped out; one experienced intermittent low back pain during PRT, but continued in the study.",100.0
663,PRECIS-2,Primary outcomes were the T25FW and the SSST.,fulltext,Primary outcomes were the T25FW and the SSST.,100.0
663,PRECIS-2,"Inclusion criteria—age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",fulltext,"inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",100.0
663,PRECIS-2,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,fulltext,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,100.0
663,PRECIS-2,The exercises progressed from three sets of 10 repetitions at 15 RM toward four sets of 8 repetitions at 8 RM.,fulltext,The exercises progressed from three sets of 10 repetitions at 15 RM toward four sets of 8 repetitions at 8 RM.,100.0
663,PRECIS-2,"In total, 75% completed more than 15 out of the 20 sessions.",fulltext, total of 75% completed more than 15 out of the 20 sessions.,96.66666666666667
663,PRECIS-2,"Exclusion criteria—co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",fulltext,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",100.0
663,PRECIS-2,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",fulltext,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",100.0
664,PRECIS-2,"The home-exercise sessions were intended to mirror the supervised sessions in terms of intensity and duration of aerobic exercise, and also included tailored exercises for strength, flexibility and balance. Participants were encouraged to seek out opportunities to exercise in the local community (e.g. healthy living centres, health walks, fitness centres, swimming pools, etc.), based on their individual preferences.",fulltext,"The homeexercise sessions were intended to mirror the supervised sessions in terms of intensity and duration of aerobic exercise, and also included tailored exercises for strength, flexibility and balance. Participants were encouraged to seek out opportunities to exercise in the local community (e.g. healthy living centres, health walks, fitness centres, swimming pools, etc.), based on their individual preferences.",99.76133651551312
664,PRECIS-2,Supervised sessions took place at a university exercise research facility.,fulltext,supervised sessions per week at a university exercise research facility ,89.1891891891892
664,PRECIS-2,"Where appropriate, participants also performed exercises for strength and control. The prescribed strength training was based on individual functional needs, as assessed by the trial physiotherapist (NS).",fulltext,"Where appropriate, participants also performed exercises for strength and control. The prescribed strength training was based on individual functional needs, as assessed by the trial physiotherapist (NS).",100.0
664,PRECIS-2,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,PRECIS-2,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.",fulltext,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.",100.0
664,PRECIS-2,"Strength training was undertaken by 48 of 60 participants in the intervention group and typically involved two to six different resistance exercises (e.g. wall press-ups, arm-curls, leg abduction, wall squats and/or regular squats, knee extensions, calf raises, sit-to-stand) each session.",fulltext,"Strength training was undertaken by 48 of 60 participants in the intervention group and typically involved two to six different resistance exercises (e.g. wall press-ups, arm-curls, leg abduction, wall squats and/or regular squats, knee extensions, calf raises, sit-to-stand) each session.",100.0
664,PRECIS-2,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,fulltext,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,100.0
664,PRECIS-2,"Inclusion criteria—Clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, 9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",100.0
664,PRECIS-2,Exclusion criteria—Comorbid conditions impairing the ability to be physically active three times per week; unwilling to be randomised; living more than 20 miles from the trial centre; already engaged in structured exercise or brisk walking ≥ 3 times per week for ≥ 30 minutes per session for at least six months.,fulltext,Exclusion criteria were comorbid conditions impairing the ability to be physically active three times per week; unwilling to be randomised; living more than 20 miles from the trial centre; already engaged in structured exercise or brisk walking ≥ 3 times per week for ≥ 30 minutes per session for at least six months.,100.0
664,PRECIS-2,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,fulltext,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,100.0
664,PRECIS-2,Aerobic exercise was the core exercise modality as it is accessible (i.e. includes community-based walking exercise) and does not require equipment.,fulltext,Aerobic exercise was the core exercise modality as it is accessible (i.e. includes community-based walking exercise) and does not require equipment.,100.0
664,PRECIS-2,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",fulltext,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",100.0
665,PRECIS-2,"Participants expressed concern about the face validity, for people with MS, of the questionnaires used for the measurement of self-reported depression, including the Beck Depression Inventory II.",fulltext,"participants expressed concern about the face validity, for people with MS, of the questionnaires used for the measurement of self-reported depression, including the Beck Depression Inventory II.",100.0
665,PRECIS-2,Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study.,fulltext,Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study.,100.0
665,PRECIS-2,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions.",fulltext,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions.",100.0
665,PRECIS-2,"In the Liverpool region, a specialist neuropsychologist, based in the acute hospital facilitated access to and provided technical advice on CCBT, but did not provide additional therapeutic input. No provision other than home-use was offered or sought.",fulltext,"In the Liverpool region, a specialist neuropsychologist, based in the acute hospital facilitated access to and provided technical advice on CCBT, but did not provide additional therapeutic input. No provision other than home-use was offered or sought.",100.0
665,PRECIS-2,"The collection of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.",fulltext,"The collection of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.",100.0
665,PRECIS-2,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",fulltext,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",100.0
665,PRECIS-2,Potential participants who were identified as having severe depression (BDI score of at least 29) or active suicidal ideas during the screening process were contacted by the study clinical psychologists and briefly assessed to understand whether the reported symptoms were typical and advised to contact their GP if deemed necessary.,fulltext,Potential participants who were identified as having severe depression (BDI score of at least 29) or active suicidal ideas during the screening process were contacted by the study clinical psychologists and briefly assessed to understand whether the reported symptoms were typical and advised to contact their GP if deemed necessary.,100.0
665,PRECIS-2,"Invitations were made between October 2008 and July 2009: face-to-face by consultants in the Sheffield Teaching Hospitals NHS Foundation Trust MS clinic (n = 288); by the Sheffield MS nurses visiting patients (n = 4); and, using ink-signed personalised letters mailed out from a neuropsychologist at Sheffield (n = 40) as well as from consultant neurologists at the Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool (n = 250).",fulltext,"Invitations were made between October 2008 and July 2009: face-to-face by consultants in the Sheffield Teaching Hospitals NHS Foundation Trust MS clinic (n = 288); by the Sheffield MS nurses visiting patients (n = 4); and, using ink-signed personalised letters mailed out from a neuropsychologist at Sheffield (n = 40) as well as from consultant neurologists at the Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool (n = 250).",100.0
665,PRECIS-2,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",fulltext,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",100.0
666,PRECIS-2,The primary endpoint was patient overall satisfaction with the medication as measured by the single-item MSQ 7-point scale (1 = extremely dissatisfied to 7 = extremely satisfied),fulltext,The primary endpoint was patient overall satisfaction with the medication as measured by the single-item MSQ 7-point scale (1 = extremely dissatisfied to 7 = extremely satisfied),100.0
666,PRECIS-2,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",fulltext,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",100.0
666,PRECIS-2,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",fulltext,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",100.0
666,PRECIS-2,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",fulltext,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",100.0
666,PRECIS-2,"Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase).",fulltext,"Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase).",100.0
666,PRECIS-2,Eligible patients were randomly assigned 1:1 to receive subcutaneous injections of GA40 (n = 431) or GA20 (n = 430).,fulltext,Eligible patients were randomly assigned 1:1 to receive subcutaneous injections of GA40 (n = 431) or GA20 (n = 430).,100.0
668,PRECIS-2,Changes in maximal walking speed were measured by recording the time taken to walk the middle 10 m of a level 14-m walkway using a stopwatch.,fulltext,Changes in maximal walking speed were measured by recording the time taken to walk the middle 10 m of a level 14-m walkway using a stopwatch.,100.0
668,PRECIS-2,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",fulltext,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",100.0
668,PRECIS-2,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,PRECIS-2,"While these were the core exercises, they could be individualized. For example, if any exercise caused discomfort, the starting position was modified or the exercise was replaced.",fulltext,"While these were the core exercises, they could be individualized. For example, if any exercise caused discomfort, the starting position was modified or the exercise was replaced.",100.0
668,PRECIS-2,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers). Each trainer directly supervised a sub-group of three or four participants.",fulltext,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers). Each trainer directly supervised a sub-group of three or four participants.",100.0
668,PRECIS-2,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score 19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,PRECIS-2,Changes in walking endurance were measured with the 2-minute walk test (2MWT).,fulltext,Changes in walking endurance were measured with the 2-minute walk test (2MWT).,100.0
668,PRECIS-2,"Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations. If interested, volunteers were asked to contact one of the researchers (KD) by telephone, during which volunteers were screened to ensure they satisfied the inclusion criteria.",fulltext,"Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations. If interested, volunteers were asked to contact one of the researchers (KD) by telephone, during which volunteers were screened to ensure they satisfied the inclusion criteria.",100.0
668,PRECIS-2,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",fulltext,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",100.0
668,PRECIS-2,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis. Where data were missing, the carry forward technique was used.",fulltext,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis. Where data were missing, the carry forward technique was used.",100.0
669,PRECIS-2,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport. Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport. Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.",100.0
669,PRECIS-2,"Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant. If a participant had been inactive, a phone call was made for enquiry. Besides, two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.",fulltext,"Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant. If a participant had been inactive, a phone call was made for enquiry. Besides, two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.",100.0
669,PRECIS-2,Interested pwMS attended an information session and jointly walked 5 km for verification of their ability.,fulltext,Interested pwMS attended an information session and jointly walked 5 km for verification of their ability.,100.0
669,PRECIS-2,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,fulltext,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,100.0
669,PRECIS-2,Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%).,fulltext,Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%).,100.0
669,PRECIS-2,Evaluation was performed at two time points (0 and 12 weeks). The EXP group completed a 12-week gradual “start-to-run” program in between time points. The WLC group was offered a comparable training program after the final measurements.,fulltext,atients were tested at two time points (0 and 12 weeks). The EXP group completed a 12-week gradual “start-torun” program in between time points. The WLC group Figure 1. Illustration of the experimental design and methods of training supervision. Multiple Sclerosis Journal 25(1) 94 journals.sagepub.com/home/msj was offered a comparable training program after the final measurements.,93.64406779661016
669,PRECIS-2,"An illustration of a training protocol is provided in supplementary material S1. During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",fulltext,"An illustration of a training protocol is provided in supplementary material S1. During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",100.0
669,PRECIS-2,"Aerobic capacity was assessed on an electronically braked cycle ergometer (eBike Basic®; General Electric GmbH, Bitz, Germany) with continuous pulmonary gas exchange analysis (Oxycon, Erich Jaeger GmbH, Germany), and heart rate (HR) monitoring (Polar ®).",fulltext,"Aerobic capacity was assessed on an electronically braked cycle ergometer (eBike Basic ® ; General Electric GmbH, Bitz, Germany) with continuous pulmonary gas exchange analysis (Oxycon, Erich Jaeger GmbH, Germany), and heart rate (HR) monitoring (Polar ® ",99.60629921259843
669,PRECIS-2,Participants received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,fulltext,S received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,94.6078431372549
669,PRECIS-2,Intention-to-treat analysis was performed.,fulltext,Intention-to-treat analysis was performed.,100.0
670,PRECIS-2,"Although further work would be beneficial, the results of this study support previous findings indicating that massage therapy increases the self-efficacy of clients with multiple sclerosis, potentially resulting in a better overall adjustment to the disease and an improvement in psycho-emotional state.",fulltext,"Although further work would be beneficial, the results of this study support previous findings indicating that massage therapy increases the self-efficacy of clients with multiple sclerosis, potentially resulting in a better overall adjustment to the disease and an improvement in psychoemotional state.",99.67105263157895
670,PRECIS-2,"All treatment plans were approved by the clinical teacher in charge. The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client’s needs.",fulltext,"All treatment plans were approved by the clinical teacher in charge. The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client’s needs.",100.0
670,PRECIS-2,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",fulltext,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",100.0
670,PRECIS-2,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",fulltext,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",100.0
670,PRECIS-2,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey.,fulltext,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey.,100.0
670,PRECIS-2,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",fulltext,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",100.0
670,PRECIS-2,"For both treatment and control groups, self-efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",fulltext,"For both treatment and control groups, self-efficacy scores were obtained before the first treatment, midtreatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",99.625468164794
670,PRECIS-2,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",fulltext,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",100.0
671,PRECIS-2,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease modifying drug, receiving steroid treatment within the preceding month, or participating in another clinical trial.",fulltext,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease modifying drug, receiving steroid treat ment within the preced ing month, or participating in another clinical trial.",100.0
671,PRECIS-2,"Outcome assessors (research therapists) were masked to treatment allocation, and all assessments were done independently and away from the participant’s home.",fulltext,"Outcome assessors (research therapists) were masked to treatment allocation, and all assessments were done independently and away from the participant’s home.",100.0
671,PRECIS-2,The primary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score23 at the primary endpoint of 36 weeks post-randomisation.,fulltext,The prim ary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score 23 at the primary endpoint of 36 weeks post randomisation.,100.0
671,PRECIS-2,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,PRECIS-2,"The person with multiple sclerosis and their standing assistant (typically their spouse) engaged in two face-to face, home based, 60 min physiotherapy sessions, aimed at setting up, implementing, and progressing the standing programme according to ability, supplemented by online advice and DVDs.",fulltext,"The person with multiple sclerosis and their standing assistant (typically their spouse) engaged in two face to face, home based, 60 min physiotherapy sessions, aimed at setting up, implementing, and progressing the standing programme according to ability, supplemented by online advice and DVDs.",100.0
671,PRECIS-2,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald’s criteria,21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",fulltext,"Key inclusion criteria were age older than 18 years, a diagnosis of pro gressive multiple sclerosis (primary or secondary) accord ing to McDonald’s criteria, 21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",100.0
671,PRECIS-2,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.,fulltext,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.,100.0
671,PRECIS-2,"In line with previous research,14 participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",fulltext,"In line with previous research, 14 participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",100.0
671,PRECIS-2,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention-to treat approach, regardless of compliance to the intervention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements (ie, there was no imputation of missing baseline or week 36 scores for the primary analysis), and used an analysis of covariance (ANCOVA) approach.",fulltext,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention to treat approach, regardless of compliance to the inter vention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements (ie, there was no imputation of missing baseline or week 36 scores for the primary analysis), and used an analysis of covariance (ANCOVA) approach.",100.0
673,PRECIS-2,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale-29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",fulltext,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",99.48979591836735
673,PRECIS-2,"Participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",fulltext,"participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",100.0
673,PRECIS-2,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,fulltext,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,100.0
673,PRECIS-2,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical.",fulltext,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical.",100.0
673,PRECIS-2,"The yoga and FI-led classes were not defined, as this pragmatic trial aimed to establish the effectiveness and content of these interventions in the manner that people with MS would likely encounter them within the community.",fulltext,"The yoga and FI-led classes were not defined, as this pragmatic trial aimed to establish the effectiveness of and content of these interventions in the manner that people with MS would likely encounter them within the community.",100.0
673,PRECIS-2,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,fulltext,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,100.0
673,PRECIS-2,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.",100.0
674,PRECIS-2,Extra test—Randomised controlled trial of Bell’s palsy treatment required senior otorhinolaryngologist in hospitals to confirm a patient’s eligibility to participate. Bell’s palsy is usually diagnosed by a general practitioner in primary care.,prompt,Extra test—Randomised controlled trial of Bell’s palsy treatment required senior otorhinolaryngologist in hospitals to confirm a patient’s eligibility to participate. Bell’s palsy is usually diagnosed by a general practitioner in primary care.,100.0
674,PRECIS-2,"Test not routinely used in primary care and requires training. It is, however, an easy clinical test widely used in secondary care for grading recovery from facial nerve paralysis caused by damage to lower motor neurons.",prompt,"Test not routinely used in primary care and requires training. It is, however, an easy clinical test widely used in secondary care for grading recovery from facial nerve paralysis caused by damage to lower motor neurons.",100.0
674,PRECIS-2,Primary outcome—Recovery of facial function as rated on the House-Brackmann scale.,prompt,Primary outcome—Recovery of facial function as rated on the House-Brackmann scale.,100.0
674,PRECIS-2,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",prompt,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",100.0
674,PRECIS-2,"Monitoring intensity involved more extensive data collection than usual: Pre-operation—three-lead electrocardiogram (ECG) Holter monitor (Flashcard with 2×48 hour recording) set up on each patient and maintained for 72 hours. Troponin values at 1, 3, and 7 days after surgery (more usual for only 1 and 3 days after surgery) ECG after randomisation and at 7 and 30 days after surgery.",prompt,"Monitoring intensity involved more extensive data collection than usual: Pre-operation—three-lead electrocardiogram (ECG) Holter monitor (Flashcard with 2×48 hour recording) set up on each patient and maintained for 72 hours. Troponin values at 1, 3, and 7 days after surgery (more usual for only 1 and 3 days after surgery) ECG after randomisation and at 7 and 30 days after surgery.",100.0
674,PRECIS-2,"Central adjudication—Photographs taken of patients were assessed and graded independently by a panel of three experts (not general practitioners, who usually assess).",prompt,"Central adjudication—Photographs taken of patients were assessed and graded independently by a panel of three experts (not general practitioners, who usually assess).",100.0
674,PRECIS-2,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",prompt,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",100.0
674,PRECIS-2,"Unscheduled follow-up visits triggered by primary outcome: a cardiovascular event (such as angina, myocardial infarction, stroke)",prompt,"Unscheduled follow-up visits triggered by primary outcome: a cardiovascular event (such as angina, myocardial infarction, stroke)",100.0
674,PRECIS-2,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,prompt,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,100.0
675,PRECIS-2,"Intention-to-treat analyses are reported. Data of missing study patients were imputed by linear multiple regression that adjusted for age, gender, and disease progression (entry EDSS score; STATISTICA 6.0).",fulltext,"Intention-to-treat analyses are reported. Data of missing study patients were imputed by linear multiple regression that adjusted for age, gender, and disease progression (entry EDSS score; STATISTICA 6.0).",100.0
675,PRECIS-2,"A total of 164 patients with MS referred themselves after having received information via the outpatient neurology clinic of the University Hospital Basel, other physicians, or advertisements posted in the Swiss Multiple Sclerosis Society Bulletin.",fulltext,"A total of 164 patients with MS referred themselves after having received information via the outpatient neurology clinic of the University Hospital Basel, other physicians, or advertisements posted in the Swiss Multiple Sclerosis Society Bulletin.",100.0
675,PRECIS-2,"MBI closely followed the program of mindfulness-based stress reduction and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills. Each class covered specific exercises and topics within the context of mindfulness training, i.e., practices during lying, sitting, and dynamic yoga postures, as well as during everyday life, e.g., stressful situations and social interactions. Mindfulness exercises included observation of sensory, affective, and cognitive domains of perceptible experience. The all-day retreat integrated familiar exercises and presented new ones. In all, 6 MBI courses for the experimental arm of the study were individually conducted by 2 experienced, certified teachers, each with ≥9 years teaching experience.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction 23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10 –15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills. Each class covered specific exercises and topics within the context of mindfulness training, i.e., practices during lying, sitting, and dynamic yoga postures, as well as during everyday life, e.g., stressful situations and social interactions. Mindfulness exercises included observation of sensory, affective, and cognitive domains of perceptible experience. The all-day retreat integrated familiar exercises and presented new ones. In all, 6 MBI courses for the experimental arm of the study were individually conducted by 2 experienced, certified teachers, each with 9 years teaching experience.",100.0
675,PRECIS-2,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",fulltext,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",100.0
675,PRECIS-2,Reported outcome measurements occurred within 2 weeks before and after intervention and 6 months postintervention.,fulltext,Reported outcome measurements occurred within 2 weeks before and after intervention and 6 months postintervention.,100.0
675,PRECIS-2,The study was conducted from February 2007 to March 2009.,fulltext,The study was conducted from February 2007 to March 2009.,100.0
675,PRECIS-2,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS and 2) an Expanded Disability Status Scale (EDSS) score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year.",fulltext,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS 21 and 2) an Expanded Disability Status Scale (EDSS) 22 score of 6 (no to moderately severe disability), with 1 step increase within the last year.",100.0
675,PRECIS-2,"The study was approved by the Ethics Commission of Both Basels and is registered at www.controlled-trials.com, ISRCTN21643919.",fulltext,"The study was approved by the Ethics Commission of Both Basels and is registered at www.controlled-trials.com, ISRCTN21643919.",100.0
675,PRECIS-2,"HRQOL was assessed with 2 inventories, one developed for patients with chronic disorders (i.e., disease-aspecific) and the other specifically for patients with MS.",fulltext,"HRQOL was assessed with 2 inventories, one developed for patients with chronic disorders (i.e., diseaseaspecific) and the other specifically for patients with MS.",99.38650306748467
675,PRECIS-2,"Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",fulltext,"Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",100.0
677,PRECIS-2,Primary outcome—Recovery of facial function as rated on the House-Brackmann scale. Test not routinely used in primary care and requires training.,prompt, Primary outcome—Recovery of facial function as rated on the House-Brackmann scale. • Test not routinely used in primary care and requires training,99.3103448275862
677,PRECIS-2,The sessions were all individual based on interaction with child and allowed for range of responses to the intervention,prompt,The sessions were all individual based on interaction with child and allowed for range of responses to the intervention,100.0
677,PRECIS-2,"Information sheets given out to participants. This is not usual practice, would it be if trial had shown this helped? Need more staff for follow up of trial participants to get diary results so more extensive data collection than usual. Otherwise no difference in provider expertise and organisation of care delivery.",prompt,"Information sheets given out to participants. This is not usual practice, would it be if trial had shown this helped? Need more staff for follow up of trial participants to get diary results so more extensive data collection than usual. Otherwise no difference in provider expertise and organisation of care delivery.",100.0
677,PRECIS-2,Intention-to-treat principle was applied with multiple imputation of data,prompt,Intention-to-treat principle was applied with multiple imputation of data,100.0
677,PRECIS-2,"Initially extra resources were used to recruit patients at 53 primary care practices. Patients were recruited via a postal questionnaire to identify symptoms and trial eligibility, not just to invite to participate.",prompt,"Initially extra resources were used to recruit patients at 53 primary care practices. Patients were recruited via a postal questionnaire to identify symptoms and trial eligibility, not just to invite to participate.",100.0
677,PRECIS-2,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",prompt,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",100.0
677,PRECIS-2,"Single centre and specialised centre (Madigan Army Medical Center, USA), unlikely to be the usual setting for most individuals receiving physiotherapy for shoulder impingement.",prompt,"Single centre and specialised centre (Madigan Army Medical Center, USA), unlikely to be the usual setting for most individuals receiving physiotherapy for shoulder impingement.",100.0
677,PRECIS-2,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,prompt,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,100.0
678,PRECIS-2,"In addition to continuing to receive usual services, patients in the fast-track group received care from a PCT. This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker.",fulltext,"In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT. 18,20 This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker,",100.0
678,PRECIS-2,"Subjects were 69 people with MS, 52 of whom took part in the trial.",fulltext,"Subjects were 69 people with MS, 52 of whom took part in the trial.",100.0
678,PRECIS-2,"Patients had one to three contacts (visits and/or phone calls) from the PCT, although a small number (around 12%) were referred for longer-term ‘‘community’’ palliative care.",fulltext,"Patients had one to three contacts (visits and/or phone calls) from the PCT, although a small number (around 12%) were referred for longer-term ‘‘community’’ palliative care.",100.0
678,PRECIS-2,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS-8), comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0e4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers’ burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",fulltext,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS8), 24,25 comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0e4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers’ burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",99.70674486803519
678,PRECIS-2,"We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient’s functional status. We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control groupdafter they received PCT), and 24 weeks.",fulltext,"We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient’s functional status (both self-report, using the United Kingdom Neurological Disability Scale [UNDS] 22 and interviewer-assessed using the Expanded Disability Status Scale [EDSS], 23 administered by a consultant neurologist [E. S.]). We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control groupdafter they received PCT), and 24 weeks.",100.0
678,PRECIS-2,Exclusion criteria included if the referring staff or the screening deemed patients had very urgent needs or were deteriorating rapidly when immediate referral to the service was offered.,fulltext,Exclusion criteria included if the referring staff or the screening deemed patients had very urgent needs or were deteriorating rapidly when immediate referral to the service was offered.,100.0
678,PRECIS-2,Educational seminars informed local health and social care professionals about the PCT.,fulltext,Educational seminars informed local health and social care professionals about the PCT.,100.0
678,PRECIS-2,Referrals were screened by a consultant in palliative medicine who was independent from delivering the service.,fulltext,Referrals were screened by a consultant in palliative medicine who was independent from delivering the service.,100.0
678,PRECIS-2,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",fulltext,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",100.0
678,PRECIS-2,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",100.0
678,PRECIS-2,"Patients in South East London, living with MS",fulltext,"Patients in South East London, living with MS",100.0
679,PRECIS-2,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES)",fulltext,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES)",100.0
679,PRECIS-2,"Components include group sessions, consultations, a theater evening, and optional joint activity.",fulltext,"components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity ",90.72164948453609
679,PRECIS-2,"CDTs were given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",fulltext,"CDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",97.83783783783784
679,PRECIS-2,Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.,fulltext,Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.,100.0
679,PRECIS-2,The completion of the questionnaires took about 45 minutes and for partners about five minutes per time point.,fulltext,The completion of the questionnaires took about 45 minutes and for partners about five minutes per time point.,100.0
679,PRECIS-2,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS [9].",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS [9].",100.0
679,PRECIS-2,All endpoints were analyzed according to the intention-to-treat principle,fulltext,All endpoints were analyzed according to the intention-to-treat principle,100.0
679,PRECIS-2,A highly pragmatic design approach would allow for full flexibility in how end user recipients engage with the intervention.,prompt,A highly pragmatic design approach would allow for full flexibility in how end user recipients engage with the intervention.,100.0
679,PRECIS-2,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",fulltext,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",100.0
679,PRECIS-2,The MS diagnosis was not confirmed by a neurologist. The criterion of EDSS ≤4.0 was checked by assessing whether the patient was self-sufficient and able to walk ≥500 meters without aid or rest [11].,fulltext, was not confirmed by a neurologist. The criterion of EDSS �4.0 was checked by assessing whether the patient was self-sufficient and able to walk �500 meters without aid or rest [11].,91.95979899497488
679,PRECIS-2,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires.",fulltext,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires ",100.0
679,PRECIS-2,"CDT focuses on the exploration of those stressors that confine patients to their physical, psychological or social roles regarding their disease and limitations; reduces relevant stressors; explores and pushes personal boundaries; and creates new personal boundaries by making optimal use of the existing potential [9].",fulltext,"CDT focuses on the exploration of those stressors that confine patients to their physical, psychological or social roles regarding their disease and limitations; reduces relevant stressors; explores and pushes personal boundaries; and creates new personal boundaries by making optimal use of the existing potential [9].",100.0
679,PRECIS-2,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",fulltext,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",100.0
679,PRECIS-2,All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS.,fulltext,All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS.,100.0
680,PRECIS-2,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II).,fulltext,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II).,100.0
680,PRECIS-2,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II); 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,fulltext,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,100.0
680,PRECIS-2,"All statistical analyses included a sample of 30 participants at pre, post and 20 weeks follow up.",fulltext,"All statistical analyses included a sample of 30 participants at pre, post and 20 weeks follow up.",100.0
680,PRECIS-2,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",fulltext,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",100.0
680,PRECIS-2,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs. For the intervention, a therapy manual was developed by the first author, which included tailored modules and skills for MS patients.",fulltext,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs. For the intervention, a therapy manual was developed by the first author, which included tailored modules and skills for MS patients.",100.0
680,PRECIS-2,All participants completed questionnaires at pre- and post-treatment and at 20 weeks follow up.,fulltext,All participants completed questionnaires at pre- and post-treatment and at 20 weeks follow up.,100.0
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital,",100.0
680,PRECIS-2,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,fulltext,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,100.0
681,PRECIS-2,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination and access to the intervention sites using their own or public transport.",fulltext,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale 33 score of 5 (ambulatory without aid or rest for 580 Clinical Rehabilitation 26(7) about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination 34 and access to the intervention sites using their own or public transport.",100.0
681,PRECIS-2,The Timed 25-Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.,fulltext,The Timed 25Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.,99.6
681,PRECIS-2,"All outcome measures were analysed on the basis of intention to treat, with all variables summarized and comparisons made between groups and over time.",fulltext,"All outcome measures were analysed on the basis of intention to treat, with all variables summarized and comparisons made between groups and over time.",100.0
681,PRECIS-2,Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.,fulltext,Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.,100.0
681,PRECIS-2,"The group session involved a 10-minute warm-up of aerobic and stretching components, 30–40 minutes of circuit exercises (Appendix 1 on-line), designed to train aerobic endurance, resistance and balance, and a 5–10 minute cool-down, involving aerobic work, stretching and relaxation.",fulltext,"The group session involved a 10-minute warm-up of aerobic and stretching components, 30–40 minutes of circuit exercises (Appendix 1 on-line), designed to train aerobic endurance, resistance and balance, and a 5–10 minute cool-down, involving aerobic work, stretching and relaxation.",100.0
681,PRECIS-2,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",100.0
681,PRECIS-2,The intervention took place at two different geographical locations (Site A and Site B).,fulltext,The intervention took place at two different geographical locations (Site A and Site B).,100.0
681,PRECIS-2,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,fulltext,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,100.0
681,PRECIS-2,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed. Participants worked at a self-regulated pace for each exercise.",fulltext,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed. Participants worked at a self-regulated pace for each exercise.",100.0
682,PRECIS-2,"MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement.",fulltext,"MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement.",100.0
682,PRECIS-2,Ambulatory and sedentary.,fulltext,Ambulatory and sedentary.,100.0
682,PRECIS-2,Primary outcome was peak oxygen consumption (VO2peak) at 12 months,fulltext,Primary outcome was peak oxygen consumption (VO 2peak ) at 12 months,100.0
682,PRECIS-2,Participants in both groups received two private training sessions with the physical therapist or exercise therapist.,fulltext,Participants in both groups received two private training sessions with the physical therapist or exercise therapist.,100.0
682,PRECIS-2,"Inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ≤5.5 on the Expanded Disability Status Scale (EDSS), even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",fulltext,"inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS), 10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",100.0
682,PRECIS-2,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed and have a further follow-up after the second year.,fulltext,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed ,73.84615384615385
682,PRECIS-2,Evaluators were blinded to the group that the participant was in.,fulltext,Evaluators were blinded to the group that the participant was in.,100.0
682,PRECIS-2,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,fulltext,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,100.0
682,PRECIS-2,The first set of analyses addressed whether the pattern of missing data was associated with the outcomes measured in this study.,fulltext,The first set of analyses addressed whether the pattern of missing data was associated with the outcomes measured in this study.,100.0
682,PRECIS-2,"The goal of the MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person.",fulltext,"The goal of the MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person.",100.0
682,PRECIS-2,"The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months.",fulltext,"The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months.",100.0
682,PRECIS-2,Multiple imputation was used for missing data with 11 imputations used in the analysis.,fulltext,Multiple imputation was used for missing Mayo et al. 5 data with 11 imputations used in the analysis.,100.0
684,PRECIS-2,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.",fulltext,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.",100.0
684,PRECIS-2,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran.",fulltext,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran.",100.0
684,PRECIS-2,"People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over and had at least three identifiable physiotherapy goals were included.",fulltext,"People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over 11 and had at least three identifiable physiotherapy goals were included.",100.0
684,PRECIS-2,Setting: Community; subjects’ homes.,fulltext,Setting: Community; subjects’ homes.,100.0
684,PRECIS-2,Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later.,fulltext,Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later.,100.0
684,PRECIS-2,"Subjects had a definite diagnosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres without resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many self-care functions and generally has effective use of arms).",fulltext,"Subjects had a definite diagnosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres without resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many selfcare functions and generally has effective use of ",98.11320754716981
684,PRECIS-2,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, was the primary outcome measure for the study.",fulltext,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, 12 was the primary outcome measure for the study.",100.0
684,PRECIS-2,In total 222 of the possible 240 physiotherapy sessions were delivered. The average number of sessions received by participants was 14.8 (out of a possible 16).,fulltext,In total 222 of the possible 240 physiotherapy sessions were delivered. The average number of sessions received by participants was 14.8 (out of a possible 16).,100.0
684,PRECIS-2,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",fulltext,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",100.0
684,PRECIS-2,"Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking part in the study.",fulltext,"Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking part in the study.",100.0
685,PRECIS-2,As findings from the Delphi study highlighted the need for flexibility and responsiveness to individuals the format of the discussion focused on individuals’ interests and concerns rather than on covering all the information contained in the booklet.,fulltext,As  ndings from the Delphi study highlighted the need for  exibility and responsiveness to individuals the format of the discussion focused on individuals’ interests and concerns rather than on covering all the information contained in the booklet.,98.4
685,PRECIS-2,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.,fulltext,The only selection criterion was that the diagnosis of MS was con rmed by the general practitioner. There were no exclusion criteria.,98.50746268656717
685,PRECIS-2,"Total scores on a postal version of the Barthel Index, a scale measuring mobility, the SF-36, and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",fulltext,"Total scores on a postal version of the Barthel Index, 11 a scale measuring mobility, 12 the United Kingdom version of the SF-36 13 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",100.0
685,PRECIS-2,Follow-up assessments were conducted six months after baseline.,fulltext, assessments were conducted six months after baseline.,85.71428571428572
685,PRECIS-2,"It was a community-based research study, which was approved by the appropriate local research ethics committees, and was conducted at the Centre for Research in Rehabilitation at Brunel University’s Osterley Campus in West London from June 1996 until February 1999.",fulltext,"It was a community-based research study, which was approved by the appropriate local research ethics committees, and was conducted at the Centre for Research in Rehabilitation at Brunel University’s Osterley Campus in West London from June 1996 until February 1999.",100.0
685,PRECIS-2,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",fulltext,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",100.0
685,PRECIS-2,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",fulltext,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",100.0
686,PRECIS-2,"For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion.",fulltext,"re 1). For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inc",95.70552147239265
686,PRECIS-2,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",fulltext,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",100.0
686,PRECIS-2,Signed informed consent was obtained for each patient at inclusion.,fulltext,Signed informed consent was obtained for each patient at inclusion.,100.0
686,PRECIS-2,Patients in the IMD group received a half-day (four to six hours) individually tailored assessment by the multidisciplinary group.,fulltext, These patients received a half-day (four to six hours) individually tailored assessment by the multidisciplinary,81.53846153846153
686,PRECIS-2,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,fulltext,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,100.0
686,PRECIS-2,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",fulltext,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",100.0
686,PRECIS-2,"Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multi-disciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist). Patients who were not living independently in the community were excluded.",fulltext,"2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neurourology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist). Patients who were not living independently in the community were exc",98.46449136276392
687,PRECIS-2,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",fulltext,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, 13 stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",100.0
687,PRECIS-2,"The primary outcome measure, the timed 25 foot walk, has good reliability and validity in the MS population.",fulltext,"The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
687,PRECIS-2,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",fulltext,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",100.0
687,PRECIS-2,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",fulltext,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",100.0
687,PRECIS-2,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,fulltext,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,100.0
687,PRECIS-2,"Participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",fulltext,"Participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",100.0
687,PRECIS-2,"Data from the 25ft walk was used to calculate the sample size required for a fully powered, randomized controlled trial.",fulltext,"Data from the 25ft walk was used to calculate the sample size required for a fully powered, randomized controlled trial.",100.0
687,PRECIS-2,"Individualised exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",fulltext,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",100.0
688,PRECIS-2,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis and live in the Rome service area.",fulltext,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis 17 and live in the ",88.53503184713377
688,PRECIS-2,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",fulltext,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",100.0
688,PRECIS-2,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,fulltext,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,100.0
688,PRECIS-2,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",fulltext,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",100.0
688,PRECIS-2,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up. A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted the different specialists according to the specific requirement.",fulltext,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up. A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted the different specialists according to the specific requirement.",100.0
688,PRECIS-2,Functional outcomes were calculated as the mean change of scores from baseline to the final follow up at 12 months.,fulltext,Functional outcomes were calculated as the mean change of scores from baseline to the final follow up at 12 months.,100.0
688,PRECIS-2,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator. These were provided with cell phones and could easily be reached for advice (telephone intervention) or direct face to face intervention when required.",fulltext,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator. These were provided with cell phones and could easily be reached for advice (telephone intervention) or direct face to face intervention when required.",100.0
688,PRECIS-2,"For each scale of the SF-36 and separately for the case and control group, we adopted a regression model in which score changes at the end of the follow up period were adjusted for the baseline values.",fulltext,"For each scale of the SF-36 and separately for the case and control group, we adopted a regression model in which score changes at the end of the follow up period were adjusted for the baseline values.",100.0
689,PRECIS-2,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months",fulltext,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months",100.0
689,PRECIS-2,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.).",fulltext,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.).",100.0
689,PRECIS-2,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score12 or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",fulltext,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score 12 or Renfrew et al. 3 relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",100.0
689,PRECIS-2,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.",fulltext,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.",100.0
689,PRECIS-2,"The primary outcome was walking speed as measured by the 5-minute self-selected walk test. Participants walked twice, once with their device and once without, resting for 20 minutes between. The total distance walked was recorded and the mean walking speed (m/s) calculated.",fulltext,"The primary outcome was walking speed as measured by the 5-minute self-selected walk test. Participants walked twice, once with their device and once without, resting for 20 minutes between. The order of testing was randomized between participants but was kept consistent for each participant throughout the trial. Participants walked at their preferred walking speed around a 9.5 m elliptical course for 5 minutes, resulting in a 10-meter shuttle length. The total distance walked was recorded and the mean walking speed (m/s) calculated.",100.0
689,PRECIS-2,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment.",fulltext,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment.",100.0
689,PRECIS-2,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",fulltext,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",100.0
690,PRECIS-2,Dyads were randomly assigned (2:1) to receive HPA or UC.,fulltext,Dyads were randomly assigned (2:1) to receive HPA or UC.,100.0
690,PRECIS-2,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",fulltext,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",100.0
690,PRECIS-2,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",fulltext,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",100.0
690,PRECIS-2,"Mean change in POS-S-MS score from baseline to 3 months was 1.1 (95% confidence interval (CI), −0.5 to 2.7) in the HPA group and −0.2 (95% CI, −2.9 to 2.6) in the UC group, with a mean between-group difference of 1.3 (95% CI, −1.7 to 4.2)",fulltext,"Mean change in POS-S-MS score from baseline to 3 months was 1.1 (95% confidence interval (CI), −0.5 to 2.7) in the HPA group and −0.2 (95% CI, −2.9 to 2.6) in the UC group, with a mean between-group difference of 1.3 (95% CI, −1.7 to 4.2)",100.0
690,PRECIS-2,"Participants were non-institutionalized adults (age ≥ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS, Expanded Disability Status Scale (EDSS) score ≥ 8.0, complex symptoms, and ≥2 unmet care needs.",fulltext,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS, 1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0, 14 complex symptoms, 15 and ⩾2 unmet care needs.",100.0
690,PRECIS-2,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information, the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician.",fulltext,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician ",100.0
690,PRECIS-2,"The blind examiners used a web-based case report form (eCRF), so that visit 1–3 data were available to HPA teams and coordination unit.",fulltext,"The blind examiners used a web-based case report form (eCRF), so that visit 1–3 data were available to HPA teams and coordination unit.",100.0
690,PRECIS-2,"Based on the principles of PC, each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker.",fulltext,"Based on the principles of PC, 17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker.",100.0
691,PRECIS-2,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) and (3) ambulatory.",fulltext,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) 16 and (3) ambulatory.",100.0
691,PRECIS-2,"These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)), (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1)) and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",fulltext,"These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)), 18 (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1)) 19 and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",100.0
691,PRECIS-2,"The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",fulltext,"The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",100.0
691,PRECIS-2,Participants assigned to the CLP arm completed all outcome measures within an identical time frame to those in the FACETS arm (see published protocol and results tables).,fulltext,Participants assigned to the CLP arm completed all outcome measures within an identical time frame to those in the FACETS arm (see published protocol 14 and results tables).,100.0
691,PRECIS-2,"The FACETS intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists).",fulltext,"The intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists).",97.36842105263158
691,PRECIS-2,"The facilitator manual provides guidance on preparation and delivery, detailed session content, notes and suggested timings, and a checklist of facilitator objectives as well as signposts to additional resources. Sessions are delivered via PowerPoint; hence can be easily replicated.",fulltext,"The facilitator manual provides guidance on preparation and delivery, detailed session content, notes and suggested timings, and a checklist of facilitator objectives as well as signposts to additional resources. Sessions are delivered via PowerPoint; hence can be easily replicated.",100.0
691,PRECIS-2,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",fulltext,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",100.0
692,PRECIS-2,All measurements were carried out at two phases of the study T1 (baseline) and T2 (eight weeks after randomization).,fulltext,All measurements were carried out at two phases of the study T1 (baseline) and T2 (eight weeks after randomization).,100.0
692,PRECIS-2,"Mobility, fatigue, and the impact of the disease on the patient’s life were measured.",fulltext,"Mobility, fatigue, and the impact of the disease on the patient’s life were measured.",100.0
692,PRECIS-2,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",fulltext,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",100.0
692,PRECIS-2,Individuals were approached by the study coordinator and asked if they would be willing to participate in it.,fulltext,Individuals were approached by the study coordinator and asked if they would be willing to participate in it.,100.0
692,PRECIS-2,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",fulltext,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",100.0
693,PRECIS-2,"Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana.",fulltext,"ssment Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Lju",94.92753623188406
693,PRECIS-2,"Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia.",fulltext,"point. Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Sl",92.47311827956989
693,PRECIS-2,"Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.",fulltext,"usion. Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective",97.08333333333333
693,PRECIS-2,"Sports climbing (SC) took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License.",fulltext," sessions. SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee L",88.88888888888889
693,PRECIS-2,A physiotherapist assessed spasticity with Modified Ashworth Scale (MAS).,fulltext,A physiotherapist assessed spasticity with Modified Ashworth Scale (MAS).,100.0
694,PRECIS-2,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.",fulltext,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) 8 once a week for 12 weeks as an addon therapy to their standard care, which remained unchanged.",99.62825278810409
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",100.0
694,PRECIS-2,The primary endpoint was the change in the BBS (difference from BBS baseline to week 12).,fulltext,The primary endpoint was the change in the BBS 10–13 (difference from BBS baseline to week 12).,100.0
694,PRECIS-2,Analyses were based on the modified intention-to-treat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment.,fulltext, Analyses were based on the modified intention-totreat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment,98.67549668874173
694,PRECIS-2,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) score between 4 and 6.5 were eligible for inclusion.,fulltext,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) 9 score between 4 and 6.5 were eligible for inclusion.,100.0
694,PRECIS-2,Hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care,fulltext,hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) 8 once a week for 12 weeks as an addon therapy to their standard care,99.4949494949495
694,PRECIS-2,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,fulltext,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,100.0
694,PRECIS-2,"Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",fulltext,"Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",100.0
694,PRECIS-2,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",fulltext,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",100.0
695,PRECIS-2,An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.,fulltext,An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.,100.0
695,PRECIS-2,"The study took place between August 1997 and March 2000 and was approved by the research ethics committee of Queen's Medical Centre (Nottingham, UK). Each participant gave written informed consent.",fulltext,"The study took place between August 1997 and March 2000 and was approved by the research ethics committee of Queen's Medical Centre (Nottingham, UK). Each participant gave written informed consent.",100.0
695,PRECIS-2,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",fulltext,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",100.0
695,PRECIS-2,"To measure well-being, we used the General Health Questionnaire (GHQ-28) in participants and main carers (for both scores higher values signify decline in function).",fulltext,"To measure well-being, we used the General Health Questionnaire (GHQ-28)16 in participants and main carers (for both scores higher values Lost to follow-up: Died: 3 2 720 CD Ward et al. signify decline in function).",100.0
695,PRECIS-2,"In the education group (EG), baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being.",fulltext,"In the education group (EG), baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being.",100.0
695,PRECIS-2,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",fulltext,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",100.0
695,PRECIS-2,"From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",fulltext,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",100.0
695,PRECIS-2,"To avoid ascertainment bias towards people already receiving specific health or social services, we used GP information as the sole method for identifying potential participants.",fulltext,"To avoid ascertainment bias towards people already receiving specific health or social services, we used GP information as the sole method for identifying potential participants.",100.0
695,PRECIS-2,Participants' homes in the City of Nottingham.,fulltext,Participants' homes in the City of Nottingham.,100.0
695,PRECIS-2,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?'",fulltext,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?'",100.0
696,PRECIS-2,Extra test—Randomised controlled trial of Bell’s palsy treatment required senior otorhinolaryngologist in hospitals to confirm a patient’s eligibility to participate. Bell’s palsy is usually diagnosed by a general practitioner in primary care.,prompt,Extra test—Randomised controlled trial of Bell’s palsy treatment required senior otorhinolaryngologist in hospitals to confirm a patient’s eligibility to participate. Bell’s palsy is usually diagnosed by a general practitioner in primary care.,100.0
696,PRECIS-2,"Test not routinely used in primary care and requires training. It is, however, an easy clinical test widely used in secondary care for grading recovery from facial nerve paralysis caused by damage to lower motor neurons.",prompt,"Test not routinely used in primary care and requires training. It is, however, an easy clinical test widely used in secondary care for grading recovery from facial nerve paralysis caused by damage to lower motor neurons.",100.0
696,PRECIS-2,Primary outcome—Recovery of facial function as rated on the House-Brackmann scale.,prompt,Primary outcome—Recovery of facial function as rated on the House-Brackmann scale.,100.0
696,PRECIS-2,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",prompt,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",100.0
696,PRECIS-2,"Central adjudication—Photographs taken of patients were assessed and graded independently by a panel of three experts (not general practitioners, who usually assess).",prompt,"Central adjudication—Photographs taken of patients were assessed and graded independently by a panel of three experts (not general practitioners, who usually assess).",100.0
696,PRECIS-2,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",prompt,"Clinical follow-up until patient left hospital (discharge or death) or until 30 days after surgery, whichever was the longer, so more than usual care.",100.0
696,PRECIS-2,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,prompt,Inclusion criteria—Patients with confirmed diagnosis: ≥16 years of age with unilateral facial nerve weakness of no identifiable cause who presented to primary care or an emergency department and could be referred to a collaborating otorhinolaryngologist <72 hours after the onset of symptoms.,100.0
697,PRECIS-2,The group program was conducted at a local community center and included four to six participants per class.,fulltext,The group program was conducted at a local community center and included four to six participants per class.,100.0
697,PRECIS-2,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",fulltext,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",100.0
697,PRECIS-2,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",fulltext,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",100.0
697,PRECIS-2,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",fulltext,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",100.0
697,PRECIS-2,"Participants attended a local community center to complete all assessments at pre-intervention (week 0), post-intervention (week 8), and at follow-up (week 16).",fulltext,"Participants attended a local community center to complete all assessments at pre-intervention (week 0), post-intervention (week 8), and at follow-up (week 16).",100.0
697,PRECIS-2,"Home exercise participants were provided with one center-based physiotherapist-led session at the commencement of the intervention period for training, and telephone support by a physiotherapist to discuss their program every 2 weeks.",fulltext,"Home exercise participants were provided with one center-based physiotherapist-led session at the commencement of the intervention period for training, and telephone support by a physiotherapist to discuss their program every 2 weeks.",100.0
697,PRECIS-2,"The primary outcome measure was gait speed, measured using the 10-meter walk test.",fulltext,"The primary outcome measure was gait speed, measured using the 10-meter walk test.",100.0
697,PRECIS-2,Data were analyzed according to the intention-to-treat principle.,fulltext, Data were analyzed according to the intention-totreat principle,96.92307692307692
697,PRECIS-2,"Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",fulltext,"Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other ",73.97769516728626
697,PRECIS-2,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,fulltext,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,100.0
705,PRECIS-2,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,fulltext,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,100.0
705,PRECIS-2,"The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches.",fulltext,"The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches ",100.0
705,PRECIS-2,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team's arena and an affiliated health club facility.",fulltext,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team_s arena and an affiliated health club facility.",99.33774834437085
705,PRECIS-2,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,fulltext,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,100.0
705,PRECIS-2,Eligible participants were male 35–65 yr old with a BMI of ≥28 kg/m2 and met PA safety requirements.,fulltext,Eligible participants were male 35–65 yr old with a BMI of Q28 kgIm j2 and met PA safety requirements ,98.0
705,PRECIS-2,Follow-up occurred at 12 wk (both groups) and 12 months (intervention group only).,fulltext,Follow-up occurred at 12 wk (both groups) and 12 months (intervention group only ,98.78048780487805
705,PRECIS-2,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site, posters, traditional media advertisements, word of mouth, direct contact at team arena).",fulltext,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena).",100.0
712,PRECIS-2,The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups,fulltext,The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups,100.0
712,PRECIS-2,VAS was used to evaluate the pain and for pre-developed questions. The women were able to classify their perception of the pain (Table 3).,fulltext,VAS was used to evaluate the pain and for predeveloped questions. The women were able to classify their perception of the pain (Table 3).,99.27536231884058
712,PRECIS-2,"We included expectant mothers of different ages and states from the 37th week in where child birth was expected any time (induced or conduced) having: dilations at ≥ 4 cm, two or more contractions in 10 minutes, skin covering the whole of the SP6 bilateral point and with a live fetus with a cephalic vertex and in good condition.",fulltext,"We included expectant mothers of different ages and states from the 37th week in where child birth was expected any time (induced or conduced) having: dilations at ≥ 4 cm, two or more contractions in 10 minutes, skin covering the whole of the SP6 bilateral point and with a live fetus with a cephalic vertex and in good condition.",100.0
712,PRECIS-2,"It was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",fulltext,"It was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",100.0
713,PRECIS-2,Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease.,fulltext,Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease.,100.0
713,PRECIS-2,Patients were recruited from each of the primary health care centres and lung physicians’ offices.,fulltext,Patients were recruited from each of the primary health care centres and lung physicians’ offices.,100.0
713,PRECIS-2,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",fulltext,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",100.0
713,PRECIS-2,The treatment site was a clinical research centre located on a university-hospital campus.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus.,100.0
713,PRECIS-2,", who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",fulltext,", who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",100.0
713,PRECIS-2,Excluded were individuals who had another major disease,fulltext,Excluded were individuals who had another major disease,100.0
713,PRECIS-2,The main approach is to work with patients and families to find out what is meaningful for them in life as regards health and jointly decide on that which is possible and relevant for each patient and family.,fulltext,The main approach is to work with patients and families to find out what is meaningful for them in life as regards health and jointly decide on that which is possible and relevant for each patient and family.,100.0
713,PRECIS-2,"Knowledge from relevant literature, e.g. the GOLD clinical guidelines was incorporated into the non-judgmental dialogue which is central in the partnership.",fulltext,"Knowledge from relevant literature, e.g. the GOLD clinical guidelines (GOLD 2014) was incorporated into the non-judgmental dialogue which is central in the partnership ",100.0
714,PRECIS-2,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient’s clinical need.,fulltext,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient’s clinical need.,100.0
714,PRECIS-2,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,fulltext,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,100.0
714,PRECIS-2,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previ-ous six months but who had not had a routine asthma review in the preceding 11 months.,fulltext,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previ,63.74999999999999
714,PRECIS-2,We wrote to all eligible patients inviting them to take part in the study.,fulltext,We wrote to all eligible patients inviting them to take part in the study.,100.0
714,PRECIS-2,"Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",fulltext,"Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",100.0
714,PRECIS-2,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care,fulltext,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care,100.0
715,PRECIS-2,Independent assessors were health professionals trained to perform joint counts and calculating the DAS28.,fulltext,Independent assessors were health professionals trained to perform joint counts and calculating the DAS28.,100.0
715,PRECIS-2,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.",fulltext,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.",100.0
715,PRECIS-2,The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.,fulltext,The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.,100.0
715,PRECIS-2,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",fulltext,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",100.0
715,PRECIS-2,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,fulltext,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,100.0
715,PRECIS-2,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",fulltext,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",100.0
715,PRECIS-2,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), age 18 years or older and the ability to complete questionnaires unaided.",fulltext,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), 29 age 18 years or older and the ability to complete questionnaires unaided.",100.0
715,PRECIS-2,This study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,fulltext,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,97.72727272727273
722,PRECIS-2,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,fulltext,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,100.0
722,PRECIS-2,"Participants randomized to the ‘polypill-based strategy’ received a polypill containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg and either atenolol 50 mg or hydrochlorothiazide 12.5 mg. Participants randomized to ‘usual care’ continued with separate medications and doses as prescribed by their doctor.",fulltext,"Participants randomized to the ‘polypill-based strategy’ received a polypill containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg and either atenolol 50 mg or hydrochlorothiazide 12.5 mg. Participants randomized to ‘usual care’ continued with separate medications and doses as prescribed by their doctor.",100.0
722,PRECIS-2,All participants were treated by their regular doctor following randomization.,fulltext,All participants were treated by their regular doctor following randomization.,100.0
722,PRECIS-2,Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor.,fulltext,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor,",100.0
722,PRECIS-2,"Participants had established CVD or an estimated five-year CVD risk of ≥15%, with indications for antiplatelet, statin and ≥2 blood pressure lowering drugs",fulltext,"Participants had established CVD or an estimated five-year CVD risk of ≥15%, with indications for antiplatelet, statin and ≥2 blood pressure lowering drugs",100.0
722,PRECIS-2,at study end; and changes in systolic BP and total cholesterol from baseline to study end.,fulltext,at study end; and changes in systolic BP and total cholesterol from baseline to study end.,100.0
722,PRECIS-2,Primary outcomes were self-reported use of indicated combination treatment,fulltext,Primary outcomes were self-reported use of indicated combination treatment,100.0
722,PRECIS-2,"We conducted a randomized, open-label trial involving 623 participants from Australian general practices.",fulltext,"We conducted a randomized, open-label trial involving 623 participants from Australian general practices.",100.0
725,PRECIS-2,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",fulltext,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",100.0
725,PRECIS-2,Follow-up was up to 2 years (until April 2013) for all patients.,fulltext,Follow-up was up to 2 years (until April 2013) for all patients.,100.0
725,PRECIS-2,"Excluded patients had associated dislocation of the injured shoulder joint, open fracture, insufficient mental capacity to understand the trial or instructions for rehabilitation, comorbidities precluding surgery or anesthesia, clear indication for surgery such as severe soft-tissue compromise, multiple injuries (upper limb fractures), pathological fracture (other than osteoporotic), terminal illness, or were not a resident in the hospital catchment area.",fulltext,"Excluded patients had associated dislocation of the injured shoulder joint, open fracture, insufficient mental capacity to understand the trial or instructions for rehabilitation, comorbidities precluding surgery or anesthesia, clear indication for surgery such as severe soft-tissue compromise, multiple injuries (upper limb fractures), pathological fracture (other than osteoporotic), terminal illness, or were not a resident in the hospital catchment area.",100.0
725,PRECIS-2,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck.,fulltext,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck.,100.0
725,PRECIS-2,"The OSS was collected by postal questionnaires at 6, 12 and 24 months.",fulltext,"The OSS was collected by postal questionnaires at 6, 12, and 24 months.",100.0
725,PRECIS-2,"Care pathways for all patients included outpatient- and community-based rehabilitation, which primarily comprised 1 or more 1-on-1 sessions with a physiotherapist that focused on restoring function.",fulltext,"Care pathways for all patients included outpatientand community-based rehabilitation, which primarily comprised 1 or more 1-on-1 sessions with a physiotherapist that focused on restoring function.",98.98989898989899
725,PRECIS-2,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",fulltext,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",100.0
725,PRECIS-2,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.",fulltext,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.",100.0
725,PRECIS-2,Patients received their allocated treatment from the recruiting hospital.,fulltext,Patients received their allocated treatment from the recruiting hospital.,100.0
733,PRECIS-2,"A three-arm, parallel-design cluster controlled trial was used, with allocation at the level of general practice in two centres (London and Nottingham/Derby).",fulltext,"A three-arm, parallel-design cluster controlled trial was used, with allocation at the level of general practice in two centres (London and Nottingham/Derby).",100.0
733,PRECIS-2,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week.,fulltext,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week.,100.0
733,PRECIS-2,Patients were eligible to participate if they were: community dwelling aged ≥65 years; independently mobile (with or without a walking aid); and physically able to take part in group exercise. Patients were excluded if they: had experienced ≥3 falls in the previous year; had unstable clinical conditions; would be unable to follow instructions about exercise safely; or were receiving palliative care.,fulltext,Patients were eligible to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise. Patients were excluded if they: • had experienced ≥3 falls in the previous year; • had unstable clinical conditions; • would be unable to follow instructions about exercise safely; or • were receiving palliative care.,100.0
733,PRECIS-2,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",fulltext,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",100.0
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.",100.0
733,PRECIS-2,"The programmes included the following progression: OEP — ankle weights and hand holds; and FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.",fulltext,"The programmes included the following progression: • OEP — ankle weights and hand holds; and • FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.",100.0
733,PRECIS-2,"Participants were followed up every 6 months after the end of the intervention period, until 24 months. The primary time point was chosen as 12 months post-intervention to match other trials.",fulltext,"Participants were followed up every 6 months after the end of the intervention period, until 24 months. The primary time point was chosen as 12 months postintervention to match other trials.",99.47643979057592
